Rachel Yang

Papers

Total Citations

H-Index

About

Dr. Rachel Yang is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for bladder cancer patients, particularly through comparative effectiveness studies of robotic and open surgical techniques. Her most-cited work, "Robotic versus open radical cystectomy for bladder cancer: evaluation of complications, survival, and opioid prescribing patterns" (2024), has already garnered 3 citations, reflecting its timely impact on clinical practice. Dr. Yang’s major contributions center on rigorously evaluating the trade-offs between minimally invasive robotic approaches and traditional open surgery, addressing critical endpoints such as postoperative complications, long-term survival, and opioid prescribing patterns—a key concern in the era of the opioid crisis. Her research provides evidence-based guidance for surgeons and patients navigating treatment decisions, balancing oncologic efficacy with recovery quality. Beyond this landmark study, Dr. Yang’s work has advanced understanding of perioperative care and pain management strategies in urologic oncology. Her findings are shaping surgical protocols and helping to reduce opioid dependence in cancer patients. With a growing citation footprint and a focus on high-impact clinical questions, Dr. Yang is establishing herself as a vital voice in the evolution of bladder cancer surgery, bridging technological innovation with patient-centered outcomes.